全球GLP-1組合產品市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球GLP-1相關產品市場預計將從2025年的2,159.9億美元成長至2034年的5,702.3億美元，預計在2026年至2034年間以11.39%的複合年成長率成長。這個市場快速成長的原因在於全球範圍內GLP-1療法在糖尿病和肥胖症治療的應用持續成長。注射配件、藥物管理工具、營養支持方案和數位健康平台等配套產品有助於提高治療依從性、提升患者便利性並改善整體治療效果。代謝性疾病盛行率的上升、體重管理意識的增強以及醫療保健服務的普及，進一步推動了對增強GLP-1療法療效的配套產品的需求。

醫療保健專業人員和醫療技術公司正在投資開發創新的患者支援解決方案，以簡化藥物管理和長期疾病管理。數位監測應用程式、連網注射設備和個人化健康指導的整合正在提高患者參與度和用藥依從性。製藥廠商和數位醫療服務提供者之間日益密切的合作正在加速產品創新。醫療保健成本的上漲以及部分地區有利的報銷政策也進一步推動了市場擴張。

隨著個人化醫療和慢性病管理的不斷發展，前景依然十分光明。人工智慧、遠端患者監護和穿戴式健康技術將增強治療追蹤和患者支援。家庭醫療保健服務的擴展和持續的產品創新將創造巨大的成長機會。隨著GLP-1療法處方的日益普及，配套產品將在提高治療效果和患者生活品質方面發揮越來越重要的作用。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球GLP-1組合產品市場：依產品分類

• 市場分析、洞察與預測
• 肌肉維持粉（蛋白質粉、即飲蛋白質飲料、蛋白棒等）
• 消化器官系統健康產品（膳食纖維補充劑、益生菌補充劑、消化酵素補充劑等）
• 營養密度支持（綜合維他命補充劑、代餐等）
• 食慾和代謝支持（飽足感支持產品、食慾管理補充劑等）
• 補水和恢復產品（電解質飲料、恢復和補水產品、功能性補水混合物等）
• 其他

第5章 全球GLP-1組合產品市場：依通路分類

• 市場分析、洞察與預測
• 大賣場和超級市場
• 藥局/藥局
• 專賣店
• D2C
• 線上（電子商務）
• 多層次傳銷（MLM）
• 其他

第6章 全球GLP-1組合產品市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott
  • Beneo
  • Danone
  • Fresenius Kabi
  • General Mills
  • Hormel Foods
  • Huel
  • Kate Farms
  • Kellogg Company
  • Medtition
  • Nestle
  • Nutricia
  • PepsiCo
  • The Kraft Heinz Company

The global GLP-1 companion products market size is expected to reach USD 570.23 Billion in 2034 from USD 215.99 Billion in 2025, growing at a CAGR of 11.39 during 2026-2034.This market is experiencing rapid growth as the adoption of GLP-1 therapies for diabetes and obesity continues to increase worldwide. Companion products, including injection accessories, medication management tools, nutritional support solutions, and digital health platforms, help improve treatment adherence, patient convenience, and overall therapeutic outcomes. Rising prevalence of metabolic disorders, increasing awareness of weight management, and expanding healthcare access are encouraging greater demand for complementary products that enhance the effectiveness of GLP-1 treatments.

Healthcare providers and medical technology companies are investing in innovative patient support solutions that simplify medication administration and long-term disease management. Integration of digital monitoring applications, connected injection devices, and personalized health coaching is improving patient engagement and adherence. Growing collaborations between pharmaceutical manufacturers and digital health providers are accelerating product innovation. Increasing healthcare expenditure and favorable reimbursement initiatives in several regions are further contributing to market expansion.

The future outlook remains highly promising as personalized medicine and chronic disease management continue evolving. Artificial intelligence, remote patient monitoring, and wearable health technologies will enhance treatment tracking and patient support. Rising adoption of home healthcare services and continuous product innovation will create significant growth opportunities. As GLP-1 therapies become more widely prescribed, companion products will play an increasingly important role in improving treatment effectiveness and patient quality of life.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Muscle Preservation Powders (Protein Powders, RTD Protein Beverages, Protein Bars, Others)
• Digestive Health Products (Fiber Supplements, Probiotics Supplements, Digestive Enzyme Supplements, Others)
• Nutrient Density Support (Multivitamin Supplements, Meal Replacement Products, Others)
• Appetite & Metabolic Support (Satiety Support Products, Appetite Management Supplements, Others)
• Hydration & Recovery Products (Electrolyte Beverages, Recovery Hydration Products, Functional Hydration Mixes, Others)
• Others

By Distribution Channel

• Hypermarkets & Supermarkets
• Pharmacies & Drug Stores
• Specialty Stores
• D2C
• Online (E-commerce)
• MLM (Direct Sales)
• Others

COMPANIES PROFILED

• Abbott, Beneo, Danone, Fresenius Kabi, General Mills, Hormel Foods, Huel, Kate Farms, Kellogg Company, Medtition, Nestle, Nutricia, PepsiCo, The Kraft Heinz Company

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GLP-1 COMPANION PRODUCTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Muscle Preservation Powders (Protein Powders, RTD Protein Beverages, Protein Bars, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Digestive Health Products (Fiber Supplements, Probiotics Supplements, Digestive Enzyme Supplements, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Nutrient Density Support (Multivitamin Supplements, Meal Replacement Products, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Appetite & Metabolic Support (Satiety Support Products, Appetite Management Supplements, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Hydration & Recovery Products (Electrolyte Beverages, Recovery Hydration Products, Functional Hydration Mixes, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GLP-1 COMPANION PRODUCTS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Hypermarkets & Supermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pharmacies & Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Specialty Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. D2C Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Online (E-commerce) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. MLM (Direct Sales) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GLP-1 COMPANION PRODUCTS MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL GLP-1 COMPANION PRODUCTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott
  • 8.2.2 Beneo
  • 8.2.3 Danone
  • 8.2.4 Fresenius Kabi
  • 8.2.5 General Mills
  • 8.2.6 Hormel Foods
  • 8.2.7 Huel
  • 8.2.8 Kate Farms
  • 8.2.9 Kellogg Company
  • 8.2.10 Medtition
  • 8.2.11 Nestle
  • 8.2.12 Nutricia
  • 8.2.13 PepsiCo
  • 8.2.14 The Kraft Heinz Company